|Number of samples:||30|
|Release date:||May 31 2018|
|Last update date:||Nov 28 2018|
|Diseases:||Neoplasms, Prostatic Neoplasms|
|Dataset link||CDK4/6 inhibitor resistance in prostate cancer|
Thirty total sample: three biological replicates of vehicle control and PD treated parental and Palbociclib (PD) resistant cells (PDR) that were generated from LAPC4 and LNCaP cells.